Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
Xiaochu Man(Shandong Tumor Hospital), Changrui Liu(Chinese People's Liberation Army), Jie Huang(Shandong Tumor Hospital), Fangchao Zheng(Shandong Tumor Hospital), Shujuan Sun(Shandong Tumor Hospital), Xianguang Zhao(Fudan University), Baoxuan Zhang(Chongqing University), Qingqing He(Chinese People's Liberation Army), Xinzhao Wang(Shandong Tumor Hospital), Bingjie Fan(Shandong Tumor Hospital), Chao Li(Shandong University), Linlin Wang(Qingdao University), Lin Dong(State Key Laboratory of Pollution Control and Resource Reuse), Zhengbo Zhou(Shandong Tumor Hospital), Dongdong Zhou(Hainan University), Hui Fu(Tianjin University of Traditional Chinese Medicine), Jinming Yu(Shandong University), Wei Huang(Central South University), Yan Zhang(Qingdao University), Shu Fang(Peking University), Liang Xu(Target (United States)), Xiao Sun(Shandong Tumor Hospital), Lihua Song(Shandong Tumor Hospital)
Cited by 6
Related Papers
Subfoveal Choroidal Thickness: The Beijing Eye Study
|Ophthalmology|2012|595
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia
|Nature Genetics|2013|485
Particulate matter deposited on leaf of five evergreen species in Beijing, China: Source identification and size distribution
|Atmospheric Environment|2015|227
Adaptive genic evolution in the <i>Drosophila</i> genomes
|Proceedings of the National Academy of Sciences|2007|227